Opaldia has initially focused on cancer surveillance, specifically for Breast and Ovarian cancers. Following from the success of these programs, Opaldia is developing screening programmes for bowel/gastro-intestinal, gynaecological, skin and prostate cancers.
These programmes are offered from leading private hospitals, specialist imaging centers and clinics in London and later this year throughout the rest of the UK.
Please follow these links to learn more about our surveillance programs;